<DOC>
	<DOCNO>NCT00112099</DOCNO>
	<brief_summary>The purpose study evaluate role splenectomy potentially curative total gastrectomy proximal gastric carcinoma term survival benefit post-operative morbidity .</brief_summary>
	<brief_title>GCSSG-SPNX : Trial Evaluate Splenectomy Total Gastrectomy Proximal Gastric Carcinoma : JCOG0110</brief_title>
	<detailed_description>European clinical trial gastrectomy show splenectomy important risk factor post-operative morbidity mortality . Retrospective comparison suggest splenectomy associated poor long term survival . However , Japanese study reveal 20 - 30 % patient non-early carcinoma proximal stomach nodal metastasis splenic hilum therefore , pancreas-preserving splenectomy part standard operation specialize center splenectomy consider risk factor operative mortality . There prospective randomized trial evaluate survival benefit splenectomy total gastrectomy proximal gastric cancer . Comparison : Total gastrectomy pancreas-preserving splenectomy versus total gastrectomy without splenectomy</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>Preoperatively Histologically proven adenocarcinoma T2 deep lesion upper third stomach without involvement great curvature esophageal invasion , irrespective primary tumor location existence multiple focus No distant metastasis , linitis plastica ( 'Borrmann 4 ' ) , stump carcinoma , prior treatment 364 Randomized trial splenectomy gastric cancer Sufficient organ function Written inform consent . Intraoperatively T2/T3/T4 N0/N1/N2 , tumor great curvature , direct invasion pancreas spleen , negative peritoneal lavage cytology No apparent nodal metastasis splenic hilum along splenic artery Liver cirrhosis portal hypertension Idiopathic thrombocytopenic purpura Severe pulmonary dysfunction Synchronous metachronous ( within 5 year ) malignancy .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>gastric neoplasm</keyword>
	<keyword>gastrectomy</keyword>
	<keyword>splenectomy</keyword>
	<keyword>randomize trial</keyword>
	<keyword>T2 , T3 T4 carcinoma proximal third stomach</keyword>
</DOC>